






 |
Mortality of HIV Disease for Death Year
Statewide by Gender, Risk and Race
2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
2000 - 2004 | 1990 - 1999 | 1980 - 1989
2010
HIV Disease |
NH Black |
NH White |
Hispanic |
Other |
Total |
Female |
Injection Drug Use (IDU) |
23 |
7 |
|
3 |
33 |
Heterosexual |
13 |
2 |
4 |
2 |
21 |
Other |
|
2 |
|
|
2 |
Risk not Reported /Unknown |
9 |
1 |
2 |
|
12 |
Total |
45 |
12 |
6 |
5 |
68 |
Male |
Male Sex w/Male (MSM) |
46 |
30 |
12 |
6 |
94 |
Injection Drug Use (IDU) |
28 |
4 |
2 |
|
34 |
MSM+IDU |
9 |
3 |
2 |
5 |
19 |
Heterosexual |
2 |
|
1 |
1 |
4 |
Risk not Reported /Unknown |
18 |
5 |
5 |
3 |
31 |
Total |
103 |
42 |
22 |
15 |
182 |
Female
+
Male |
Male Sex w/Male (MSM) |
46 |
30 |
12 |
6 |
94 |
Injection Drug Use (IDU) |
51 |
11 |
2 |
3 |
67 |
MSM+IDU |
9 |
3 |
2 |
5 |
19 |
Heterosexual |
15 |
2 |
5 |
3 |
25 |
Other |
|
2 |
|
|
2 |
Risk not Reported /Unknown |
27 |
6 |
7 |
3 |
43 |
Total |
148 |
54 |
28 |
20 |
250 |
2009
HIV Disease |
NH Black |
NH White |
Hispanic |
Other |
Total |
Female |
Injection Drug Use (IDU) |
16 |
3 |
2 |
|
21 |
Heterosexual |
17 |
4 |
3 |
|
24 |
Perinatal Exposure |
2 |
|
|
|
2 |
Risk not Reported /Unknown |
5 |
|
2 |
|
7 |
Total |
40 |
7 |
7 |
|
54 |
Male |
Male Sex w/Male (MSM) |
22 |
18 |
3 |
2 |
45 |
Injection Drug Use (IDU) |
25 |
3 |
4 |
|
32 |
MSM+IDU |
14 |
4 |
1 |
1 |
20 |
Heterosexual |
6 |
1 |
|
|
7 |
Perinatal Exposure |
|
1 |
|
|
1 |
Risk not Reported /Unknown |
14 |
9 |
2 |
|
25 |
Total |
81 |
36 |
10 |
3 |
130 |
Female
+
Male |
Male Sex w/Male (MSM) |
22 |
18 |
3 |
2 |
45 |
Injection Drug Use (IDU) |
41 |
6 |
6 |
|
53 |
MSM+IDU |
14 |
4 |
1 |
1 |
20 |
Heterosexual |
23 |
5 |
3 |
|
31 |
Perinatal Exposure |
2 |
1 |
|
|
3 |
Risk not Reported /Unknown |
19 |
9 |
4 |
|
32 |
Total |
121 |
43 |
17 |
3 |
184 |
2008
HIV Disease |
NH Black |
NH White |
Hispanic |
Other |
Unknown/ Missing |
Total |
Female |
Injection Drug Use (IDU) |
61 |
15 |
4 |
1 |
|
81 |
Heterosexual |
33 |
8 |
9 |
|
|
50 |
Other |
1 |
|
1 |
|
|
2 |
Risk not Reported /Unknown |
21 |
1 |
|
2 |
1 |
25 |
Total |
116 |
24 |
14 |
3 |
1 |
158 |
Male |
Male Sex w/Male (MSM) |
100 |
84 |
10 |
4 |
|
198 |
Injection Drug Use (IDU) |
88 |
13 |
6 |
|
|
107 |
MSM+IDU |
34 |
10 |
4 |
|
|
48 |
Heterosexual |
15 |
13 |
6 |
|
|
34 |
Perinatal Exposure |
|
1 |
|
|
|
1 |
Other |
2 |
1 |
|
|
|
3 |
Risk not Reported /Unknown |
38 |
12 |
6 |
|
1 |
57 |
Total |
277 |
134 |
32 |
4 |
1 |
448 |
Female
+
Male |
Male Sex w/Male (MSM) |
100 |
84 |
10 |
4 |
|
198 |
Injection Drug Use (IDU) |
149 |
28 |
10 |
1 |
|
188 |
MSM+IDU |
34 |
10 |
4 |
|
|
48 |
Heterosexual |
48 |
21 |
15 |
|
|
84 |
Perinatal Exposure |
|
1 |
|
|
|
1 |
Other |
3 |
1 |
1 |
|
|
5 |
Risk not Reported /Unknown |
59 |
13 |
6 |
2 |
2 |
82 |
Total |
393 |
158 |
46 |
7 |
2 |
606 |
2007
HIV Disease |
NH Black |
NH White |
Hispanic |
Other |
Unknown/
Missing |
Total |
Female |
Injection Drug Use (IDU) |
59 |
18 |
3 |
2 |
|
82 |
Heterosexual |
38 |
11 |
5 |
1 |
|
55 |
Perinatal Exposure |
1 |
|
|
|
|
1 |
Risk not Reported /Unknown |
24 |
6 |
|
|
1 |
31 |
Total |
122 |
35 |
8 |
3 |
1 |
169 |
Male |
Male Sex w/Male (MSM) |
113 |
83 |
19 |
3 |
|
218 |
Injection Drug Use (IDU) |
99 |
22 |
17 |
2 |
1 |
141 |
MSM+IDU |
46 |
12 |
2 |
|
|
60 |
Heterosexual |
20 |
2 |
3 |
|
|
25 |
Other |
2 |
1 |
1 |
|
|
4 |
Risk not Reported /Unknown |
50 |
11 |
8 |
1 |
|
70 |
Total |
330 |
131 |
50 |
6 |
1 |
518 |
Female
+
Male |
Male Sex w/Male (MSM) |
113 |
83 |
19 |
3 |
|
218 |
Injection Drug Use (IDU) |
158 |
40 |
20 |
4 |
1 |
223 |
MSM+IDU |
46 |
12 |
2 |
|
|
60 |
Heterosexual |
58 |
13 |
8 |
1 |
|
80 |
Perinatal Exposure |
1 |
|
|
|
|
1 |
Other |
2 |
1 |
1 |
|
|
4 |
Risk not Reported /Unknown |
74 |
17 |
8 |
1 |
1 |
101 |
Total |
452 |
166 |
58 |
9 |
2 |
687 |
2006
HIV Disease |
NH Black |
NH White |
Hispanic |
Other |
Total |
Female |
Injection Drug Use (IDU) |
62 |
19 |
9 |
1 |
91 |
Heterosexual |
59 |
10 |
7 |
1 |
77 |
Perinatal Exposure |
1 |
|
|
|
1 |
Other |
1 |
|
|
|
1 |
Risk not Reported /Unknown |
27 |
2 |
1 |
1 |
31 |
Total |
150 |
31 |
17 |
3 |
201 |
Male |
Male Sex w/Male (MSM) |
98 |
100 |
22 |
6 |
226 |
Injection Drug Use (IDU) |
118 |
20 |
18 |
3 |
159 |
MSM+IDU |
32 |
24 |
5 |
3 |
64 |
Heterosexual |
19 |
2 |
1 |
1 |
23 |
Perinatal Exposure |
|
1 |
|
|
1 |
Other |
|
3 |
|
|
3 |
Risk not Reported /Unknown |
50 |
21 |
12 |
2 |
85 |
Total |
317 |
171 |
58 |
15 |
561 |
Female
+
Male |
Male Sex w/Male (MSM) |
98 |
100 |
22 |
6 |
226 |
Injection Drug Use (IDU) |
180 |
39 |
27 |
4 |
250 |
MSM+IDU |
32 |
24 |
5 |
3 |
64 |
Heterosexual |
78 |
12 |
8 |
2 |
100 |
Perinatal Exposure |
1 |
1 |
|
|
2 |
Other |
1 |
3 |
|
|
4 |
Risk not Reported /Unknown |
77 |
23 |
13 |
3 |
116 |
Total |
467 |
202 |
75 |
18 |
762 |
2005
HIV Disease |
NH Black |
NH White |
Hispanic |
Other |
Total |
Female |
Injection Drug Use (IDU) |
64 |
13 |
2 |
|
79 |
Heterosexual |
42 |
8 |
10 |
2 |
62 |
Perinatal Exposure |
2 |
|
|
|
2 |
Risk not Reported /Unknown |
17 |
1 |
3 |
2 |
23 |
Total |
125 |
22 |
15 |
4 |
166 |
Male |
Male Sex w/Male (MSM) |
111 |
101 |
21 |
4 |
237 |
Injection Drug Use (IDU) |
113 |
21 |
16 |
|
150 |
MSM+IDU |
51 |
19 |
7 |
1 |
78 |
Heterosexual |
29 |
7 |
8 |
1 |
45 |
Other |
|
1 |
|
|
1 |
Risk not Reported /Unknown |
54 |
12 |
6 |
|
72 |
Total |
358 |
161 |
58 |
6 |
583 |
Female
+
Male |
Male Sex w/Male (MSM) |
111 |
101 |
21 |
4 |
237 |
Injection Drug Use (IDU) |
177 |
34 |
18 |
|
229 |
MSM+IDU |
51 |
19 |
7 |
1 |
78 |
Heterosexual |
71 |
15 |
18 |
3 |
107 |
Perinatal Exposure |
2 |
|
|
|
2 |
Other |
|
1 |
|
|
1 |
Risk not Reported /Unknown |
71 |
13 |
9 |
2 |
95 |
Total |
483 |
183 |
73 |
10 |
749 |
2000 - 2004
AIDS |
NH Black |
NH White |
Hispanic |
Other |
Total |
Female |
Injection Drug Use (IDU) |
326 |
72 |
32 |
11 |
441 |
Heterosexual |
198 |
53 |
46 |
4 |
301 |
Perinatal Exposure |
8 |
|
1 |
|
9 |
Other |
3 |
1 |
|
|
4 |
Risk not Reported /Unknown |
63 |
15 |
10 |
|
88 |
Total |
598 |
141 |
89 |
15 |
843 |
Male |
Male Sex w/Male (MSM) |
436 |
433 |
102 |
9 |
980 |
Injection Drug Use (IDU) |
553 |
102 |
79 |
3 |
737 |
MSM+IDU |
203 |
60 |
35 |
4 |
302 |
Heterosexual |
93 |
24 |
18 |
1 |
136 |
Perinatal Exposure |
3 |
1 |
2 |
|
6 |
Other |
8 |
11 |
2 |
1 |
22 |
Risk not Reported /Unknown |
124 |
49 |
33 |
5 |
211 |
Total |
1420 |
680 |
271 |
23 |
2394 |
Female
+
Male |
Male Sex w/Male (MSM) |
436 |
433 |
102 |
9 |
980 |
Injection Drug Use (IDU) |
879 |
174 |
111 |
14 |
1178 |
MSM+IDU |
203 |
60 |
35 |
4 |
302 |
Heterosexual |
291 |
77 |
64 |
5 |
437 |
Perinatal Exposure |
11 |
1 |
3 |
|
15 |
Other |
11 |
12 |
2 |
1 |
26 |
Risk not Reported /Unknown |
187 |
64 |
43 |
5 |
299 |
Total |
2018 |
821 |
360 |
38 |
3237 |
1990 - 1999
AIDS |
NH Black |
NH White |
Hispanic |
Other |
Total |
Female |
Injection Drug Use (IDU) |
638 |
225 |
71 |
11 |
945 |
Heterosexual |
299 |
145 |
67 |
2 |
513 |
Perinatal Exposure |
29 |
8 |
9 |
|
46 |
Other |
22 |
25 |
6 |
|
53 |
Risk not Reported /Unknown |
83 |
23 |
14 |
3 |
123 |
Total |
1071 |
426 |
167 |
16 |
1680 |
Male |
Male Sex w/Male (MSM) |
2376 |
3641 |
582 |
53 |
6652 |
Injection Drug Use (IDU) |
1741 |
429 |
393 |
12 |
2575 |
MSM+IDU |
368 |
269 |
77 |
3 |
717 |
Heterosexual |
184 |
82 |
67 |
4 |
337 |
Perinatal Exposure |
28 |
7 |
6 |
1 |
42 |
Other |
39 |
133 |
16 |
|
188 |
Risk not Reported /Unknown |
137 |
108 |
65 |
5 |
315 |
Total |
4873 |
4669 |
1206 |
78 |
10826 |
Female
+
Male |
Male Sex w/Male (MSM) |
2376 |
3641 |
582 |
53 |
6652 |
Injection Drug Use (IDU) |
2379 |
654 |
464 |
23 |
3520 |
MSM+IDU |
368 |
269 |
77 |
3 |
717 |
Heterosexual |
483 |
227 |
134 |
6 |
850 |
Perinatal Exposure |
57 |
15 |
15 |
1 |
88 |
Other |
61 |
158 |
22 |
|
241 |
Risk not Reported /Unknown |
220 |
131 |
79 |
8 |
438 |
Total |
5944 |
5095 |
1373 |
94 |
12506 |
1980 - 1989
HIV Disease |
NH Black |
NH White |
Hispanic |
Other |
Total |
Female |
Injection Drug Use (IDU) |
34 |
21 |
9 |
2 |
66 |
Heterosexual |
17 |
11 |
12 |
1 |
41 |
Perinatal Exposure |
4 |
4 |
2 |
|
10 |
Other |
5 |
22 |
4 |
3 |
34 |
Risk not Reported /Unknown |
13 |
5 |
2 |
1 |
21 |
Total |
73 |
63 |
29 |
7 |
172 |
Male |
Male Sex w/Male (MSM) |
532 |
1120 |
140 |
6 |
1798 |
Injection Drug Use (IDU) |
126 |
58 |
73 |
|
257 |
MSM+IDU |
39 |
76 |
9 |
1 |
125 |
Heterosexual |
14 |
5 |
4 |
|
23 |
Perinatal Exposure |
7 |
6 |
6 |
|
19 |
Other |
11 |
80 |
6 |
1 |
98 |
Risk not Reported /Unknown |
30 |
27 |
15 |
1 |
73 |
Total |
759 |
1372 |
253 |
9 |
2393 |
Female +
Male |
Male Sex w/Male (MSM) |
532 |
1120 |
140 |
6 |
1798 |
Injection Drug Use (IDU) |
160 |
79 |
82 |
2 |
323 |
MSM+IDU |
39 |
76 |
9 |
1 |
125 |
Heterosexual |
31 |
16 |
16 |
1 |
64 |
Perinatal Exposure |
11 |
10 |
8 |
|
29 |
Other |
16 |
102 |
10 |
4 |
132 |
Risk not Reported /Unknown |
43 |
32 |
17 |
2 |
94 |
Total |
832 |
1435 |
282 |
16 |
2565 |

 |
|
Illinois Department
of Public Health
535 West Jefferson Street
Springfield, Illinois 62761
Phone 217-782-4977
Fax 217-782-3987
TTY 800-547-0466
Questions or Comments |
|